News

CIDRAP4d
Studies estimate 75% RSV vaccine efficacy in older adults, profile risk for poor outcomes
Of the RSV patients aged 60 or older, 23.0% were admitted to an ICU, 31.5% had acute organ failure, and 9.8% received IMV or ...
McKnight's Long-Term Care News5d
RSV vaccines protect older adults with 75 percent effectiveness, study finds
A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged ...